Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
- Citation:
- Pharmacogenomics J vol 24 (2)
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233196, UG1CA233270, UG1CA233290, UG1CA233320, UG1CA233327, UG1CA233341, (PGRN) GM61390, U01GM61393, (NINR) P30NR014129, U10CA180820 (ECOG-ACRIN)
- Corr. Author:
- Authors:
- Jai N. Patel Chen Jiang Kouros Owzar Daniel L. Hertz Janey Wang Flora A. Mulkey William K. Kelly Susan Halabi Yoichi Furukawa Cameron Lassiter Susan G. Dorsey Paula N. Friedman Eric J. Small Michael A. Carducci Michael J. Kelley Yusuke Nakamura Michiaki Kubo Mark J. Ratain Michael J. Morris Howard L. McLeod
- Networks:
- CA136, LAPS-IL036, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NY016
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: